Alan Freudenstein is a Managing Director of Credit Suisse in the Asset Management business and Managing Partner of Credit Suisse NEXT Investors, LLC, based in New York. He sits on the board of Actiance, BATS, Ensyn, US Health Group and VITEOS.
Prior to his current role, Alan led the bank’s Principal Investment Group within the Investment Banking division.
Alan joined Credit Suisse in 2000 from Bankers Trust Company where he was a Managing Director responsible for incubation and venture investments within the New World Ventures Group. Previously, he was a management consultant at Booz Allen & Hamilton and an equity research analyst at Salomon Brothers.
Alan received a B.A. in Economics from Johns Hopkins University and an M.B.A. from the University of Chicago.